With a market capitalization of $1 trillion, Eli Lilly and Company (LLY) is a global pharmaceutical company focused on ...

BofA Securities raised its price target on Eli Lilly to $1,251 from $1,133 and kept a Buy rating, saying the drugmaker remains well place ...

Eli Lilly (LLY 1.87%) just delivered another fantastic quarter, showcasing its impressive growth prospects. The company has ...

At first glance, Eli Lilly's (NYSE: LLY) current share price of $903 feels like a psychological barrier. Most investors fixate on the absolute dollars and assume anything this expensive must be priced ...

Eli Lilly (NYSE:LLY | LLY Price Prediction) is growing like a software company. Q1 2026 revenue hit $19.80B, up 55.5% year ...

While Eli Lilly has slightly lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Eli Lilly's robust guidance despite higher costs on acquisitions and underwhelming performance by Foundayo indicates its ...

Shares of Eli Lilly and Company LLY have declined 5.2% in the past month despite the company reporting robust fourth-quarter 2025 results on Feb. 4. Industry pricing concerns, rising competitive ...

The company is riding an incredible tailwind.